Enterprise Solutions Webinars

  1. Resilience Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Hear from Evan Pasenello, Head of Commercial Services, about how Resilience can support large molecule programs from early phase through clinical and commercial manufacturing.

  2. Providing Development And Supply Of Life-Changing Medicines 7/28/2025

    Review the strategic application of extensive expertise in microbial systems to meet the increasing demand for novel biologics. Cutting-edge capabilities ensure streamlined development and manufacturing processes.

  3. Cytovance Biologics Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Thomas Kohl, Director of Business Development, shares the company’s microbial and mammalian capabilities and their available capacity. Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.

  4. Aragen Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Aragen’s newly built cutting-edge biologics manufacturing facility launches with GMP capabilities from 50L to 2000L—scaling to 5000L soon—with a DP filling line and ADC conjugation suite set to redefine bioproduction in India.

  5. PCI Pharma Services Capacity Update July 2025: Fill/Finish 7/28/2025

    PCI is positioned to meet the future of sterile pharmaceutical development and manufacturing with cutting-edge technology, and innovative solutions for high-value biologics, complex formulations, and lyophilized drug products.

  6. Novartis Contract Manufacturing Capacity Update July 2025: Fill/Finish 7/28/2025

    Novartis Contract Manufacturing introduces their fill and finish solutions and capacity. Explore an overview of the aseptic network of Novartis and the capabilities of each site.

  7. INCOG BioPharma Services Capacity Update July 2025: Fill/Finish 7/28/2025

    Our balanced framework addresses the unique challenges of sterile manufacturing by integrating risk-based decision making with systematic capacity planning.

  8. Afton Scientific Capacity Update July 2025: Fill/Finish 7/28/2025

    Gain an overview of a new state-of-the-art Groninger filling line’s capabilities, production scale-up timelines, and how this new infrastructure supports product flexibility and long-term growth for our partners in the injectable drug product space.

  9. Reducing CMC Risk With Proven Analytical And Formulation Expertise 7/28/2025

    Explore real examples of how this outsourcing partner helps drug sponsors through transparency that empowers, integration that simplifies, methods that de-risk, and experience that accelerates.

  10. Contract GMP Biologics Analytical Services 7/28/2025

    Pedro Morales, Director, Scientific Advisor of Biologics Analytical Services, explores how Catalent delivers tailored solutions through deep expertise and advanced capabilities.